MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Dare Bioscience, Inc. (DARE)

Dare Bioscience, Inc. (DARE)

|||

Balance Sheets Overview

Current Ratio
98.60%
Quick Ratio
98.60%
Cash Ratio
74.56%
Debt to Asset Ratio
102.50%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses
    • Other non-current assets
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Deferred grant funding
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
12,617,594
18,519,784
24,711,356
23,075,261
Prepaid expenses
2,776,722
1,770,844
-
-
Other receivables
-
-
-
369,157
Other receivables
456,429
687,756
-
53,159
Other current assets
835,418
680,753
2,352,523
1,506,603
Total current assets
16,686,163
21,659,137
27,063,879
25,004,180
Property and equipment, net
1,419,796
1,448,990
1,558,890
1,657,255
Operating lease right-of-use assets
837,596
969,256
1,097,580
824,693
Finance lease right-of-use asset
872,388
1,308,581
1,744,775
2,244,073
Other non-current assets
2,554,166
2,442,450
1,009,439
1,018,373
Total assets
22,370,109
27,828,414
32,474,563
30,748,574
Accounts payable
762,914
1,231,086
1,200,686
1,844,862
Accrued expenses
448,945
529,325
725,184
2,324,931
Deferred grant funding
14,954,724
18,150,459
19,651,452
14,557,265
Current portion of liability related to the sale of future royalties
12,170
12,035
11,711
10,542
Current portion of lease liabilities, operating
594,493
598,556
602,552
609,224
Current portion of lease liability, finance
149,374
597,552
1,494,102
1,869,570
Total current liabilities
16,922,620
21,119,013
23,685,687
21,216,394
Deferred revenue, non-current
-
-
0
1,000,000
Liability related to the sale of future royalties, net
5,733,717
5,556,697
5,386,877
5,220,525
Lease liabilities long-term, operating
273,872
418,253
559,365
288,566
Lease liability long-term, finance
-
-
-
165,186
Total liabilities
22,930,209
27,093,963
29,631,929
27,890,671
Preferred stock, 0.01 par value, 5,000,000 shares authorized 4,999,620 and 0 designated series a convertible preferred stock at june30, 2026 and december31, 2025, respectively 75,900 and 0 issued and outstanding at june30, 2026 and december31, 2025, respectively. liquidation preference of 0.4 million and 0 at june30, 2026 and december31, 2025, respectively
759
656
-
-
Common stock, 0.0001 par value 240,000,000 shares authorized 15,169,502 and 14,499,502 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
1,517
1,456
1,450
1,393
Additional paid-in capital
194,484,046
192,798,213
191,951,711
190,499,662
Accumulated other comprehensive loss
-374,856
-377,081
-421,623
-395,966
Accumulated deficit
-194,671,566
-191,688,793
-188,688,904
-187,247,186
Total stockholders' (deficit) equity
-560,100
734,451
2,842,634
2,857,903
Total liabilities and stockholders' (deficit) equity
22,370,109
27,828,414
32,474,563
30,748,574
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$12,617,594 (150.60%↑ Y/Y)Prepaid expenses$2,776,722 (101.31%↑ Y/Y)Other current assets$835,418 (-39.43%↓ Y/Y)Other receivables$456,429 (142.63%↑ Y/Y)Total current assets$16,686,163 (152.73%↑ Y/Y)Other non-currentassets$2,554,166 (138.73%↑ Y/Y)Property and equipment,net$1,419,796 (-14.04%↓ Y/Y)Finance leaseright-of-use asset$872,388 (-67.69%↓ Y/Y)Operating leaseright-of-use assets$837,596 (-12.35%↓ Y/Y)Total assets$22,370,109 (72.35%↑ Y/Y)Accumulated deficit-$194,671,566 (-5.98%↓ Y/Y)Accumulated othercomprehensive loss-$374,856 (6.94%↑ Y/Y)Total liabilities andstockholders' (deficit)...$22,370,109 (72.35%↑ Y/Y)Total stockholders'(deficit) equity-$560,100 (95.60%↑ Y/Y)Additional paid-in capital$194,484,046 (13.50%↑ Y/Y)Common stock, 0.0001par value...$1,517 (68.00%↑ Y/Y)Preferred stock, 0.01 parvalue, 5,000,000...$759 Total liabilities$22,930,209 (-10.82%↓ Y/Y)Total currentliabilities$16,922,620 (-11.96%↓ Y/Y)Liability related to thesale of future...$5,733,717 (17.52%↑ Y/Y)Lease liabilitieslong-term, operating$273,872 (-38.90%↓ Y/Y)Deferred grant funding$14,954,724 (21.32%↑ Y/Y)Accounts payable$762,914 (-56.72%↓ Y/Y)Current portion of leaseliabilities, operating$594,493 (1.02%↑ Y/Y)Accrued expenses$448,945 (-82.21%↓ Y/Y)Current portion of leaseliability, finance$149,374 (-91.84%↓ Y/Y)Current portion ofliability related to the...$12,170 (-93.53%↓ Y/Y)